Skip to product information
1 of 1

Farmitalia

Macmiror Complex 10 g + 4 000 000 IU 30 g cream

Macmiror Complex 10 g + 4 000 000 IU 30 g cream

Regular price €17,10
Regular price €18,00 Sale price €17,10
Sale Sold out
Taxes included. Shipping calculated at checkout.
Logo Farmaci da banco

NET WEIGHT OF THE PRODUCT

30g

EAN

023432014

MINSAN

023432014

View full details

In ottemperanza all'articolo 118 “autorizzazione della pubblicità presso il pubblico” del decreto legislativo 24 aprile 2006, numero 219

INDICATIONS

Multipurpose therapy of vulvovaginal diseases caused by pathogenic microorganisms: Candida, Trichomonas and bacteria.

 

ACTIVE INGREDIENTS

100 g of cream contains: 10 g nifuratel; nystatin I.U. 4,000,000. For the full list of excipients, see section 6.1.

 

EXCIPIENTS

100 g of cream contain: xalifin 15; methyl p-hydroxybenzoate; propyl p-hydroxybenzoate; glycerine; sorbitol 70%; propylene glycol; carbomer; triethanolamine 30% w/v; deionized water.

 

CONTRAINDICATIONS AND SIDE EFFECTS

Hypersensitivity to the active substances or to any of the excipients listed in paragraph 6.1.

 

DOSAGE

2.5 g of cream, once or twice a day, in the evening and/or in the morning. The necessary dose of cream will be applied with an applicator.

 

CONSERVATION

Nothing to report.

 

WARNINGS

Use of the product, especially if prolonged, can give rise to sensitization phenomena. In the event of the appearance of a hypersensitivity reaction, the administration of the drug must be interrupted. During treatment, abstain from sexual intercourse.

 

INTERACTIONS

No drug interactions have been described with the components of MACMIROR COMPLEX.

 

SIDE EFFECTS

No side effects have been described after using the drug. Reporting of suspected adverse reactions. Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

 

OVERDOSE

Not to be considered, given the route of administration.

 

PREGNANCY AND BREASTFEEDING

There are no contraindications in this regard.

 

EFFECTS ON DRIVING ABILITY

No negative effects are reported.

1 of 4

Content Responsibility This sheet contains information that is not intended to replace a diagnosis or medical advice, as only the doctor can draw up any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first. Please note The names of the products, the ingredients and the percentages indicated in the descriptions are purely indicative, they may be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting in real time to such updates, the photos and technical information of the products inserted on Dottortili.com may differ from those reported on the label or otherwise disseminated by the manufacturing companies. The only identification element is the MINSAN ministerial code. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines all responsibility for any errors, omissions or failure to update the same. Dottortili.com does not assume responsibility for damages of any nature that may arise from access to the information published. Data source: Farmadati Italia Website: www.farmadati.it The Farmadati Italia Database is used by almost all pharmacies, parapharmacies, herbalist shops, health shops, large-scale retail trade, computerized doctors, etc. thanks to the company's historical guarantee of reliability, seriousness and professionalism on the national territory. The Farmadati Italia Srl management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO/IEC 27001:2017 for information security management systems.